|
|
|
Insider
Information: |
Kiener Peter A |
Relationship: |
Director |
City: |
Gaithersburg |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
357 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$162 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
357 |
|
|
Total
Value |
$162 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-6.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Medimmune Inc |
MEDI |
SVP, Research |
2006-02-08 |
0 |
2006-02-08 |
0 |
Premium* |
|
Sucampo Pharmaceuticals, Inc. |
SCMP |
Chief Science Officer |
2018-02-13 |
0 |
2016-03-31 |
0 |
Premium* |
|
Cue Biopharma, Inc. |
CUE |
Director |
2023-03-23 |
357 |
2021-11-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Scientific Officer |
|
2016-03-31 |
4 |
A |
$9.29 |
$1,198 |
D/D |
129 |
129 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Scientific Officer |
|
2016-06-30 |
4 |
A |
$9.32 |
$2,796 |
D/D |
300 |
429 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Scientific Officer |
|
2016-09-30 |
4 |
A |
$9.38 |
$3,002 |
D/D |
320 |
749 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Scientific Officer |
|
2016-12-31 |
4 |
A |
$10.46 |
$3,002 |
D/D |
287 |
1,036 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Scientific Officer |
|
2017-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
70,000 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Science Officer |
|
2017-03-31 |
4 |
A |
$9.35 |
$3,001 |
D/D |
321 |
1,357 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Science Officer |
|
2017-06-30 |
4 |
A |
$8.93 |
$3,000 |
D/D |
336 |
1,693 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Science Officer |
|
2017-09-30 |
4 |
A |
$9.10 |
$3,003 |
D/D |
330 |
2,023 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Science Officer |
|
2017-12-07 |
4 |
AS |
$16.50 |
$825,000 |
D/D |
(50,000) |
2,023 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Science Officer |
|
2017-12-07 |
4 |
OE |
$8.33 |
$416,500 |
D/D |
50,000 |
52,023 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Science Officer |
|
2017-12-28 |
4 |
D |
$17.98 |
$494,378 |
D/D |
(27,496) |
44,527 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Science Officer |
|
2017-12-31 |
4 |
A |
$9.10 |
$2,994 |
D/D |
329 |
44,856 |
0 |
- |
|
SCMP |
Sucampo Pharmaceuticals, ... |
Chief Science Officer |
|
2018-02-13 |
4 |
D |
$18.00 |
$807,408 |
D/D |
(44,856) |
0 |
0 |
- |
|
MEDI |
Medimmune Inc |
SVP, Research |
|
2006-02-08 |
4 |
S |
$33.41 |
$400,955 |
D/D |
(12,000) |
0 |
|
- |
|
MEDI |
Medimmune Inc |
SVP, Research |
|
2006-02-08 |
4 |
OE |
$23.45 |
$281,400 |
D/D |
12,000 |
12,000 |
|
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2021-11-15 |
4 |
AS |
$17.92 |
$337,165 |
D/D |
(18,815) |
0 |
0 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2021-11-15 |
4 |
OE |
$2.86 |
$53,811 |
D/D |
18,815 |
18,815 |
0 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2021-11-16 |
4 |
OE |
$2.86 |
$3,892 |
D/D |
1,361 |
1,361 |
0 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2021-11-16 |
4 |
AS |
$18.02 |
$24,525 |
D/D |
(1,361) |
0 |
0 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2023-03-23 |
4 |
S |
$3.28 |
$30,586 |
D/D |
(9,325) |
357 |
0 |
% |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2023-03-23 |
4 |
OE |
$2.86 |
$27,691 |
D/D |
9,682 |
9,682 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|